KHINDIVI

LIVE

Serial Number

98740770

Owner

Eton Pharmaceuticals, Inc.

Attorney

Andrew D. Bochner

First Use Date

Jun 3, 2025

Filing Date

Sep 9, 2024

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

KHINDIVI Trademark

Serial Number: 98740770 • Registration: 8369725

KHINDIVI is a trademark filed by Eton Pharmaceuticals, Inc. on September 9, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Eton Pharmaceuticals, Inc. (2 trademarks)

21925 Field Parkway, Suite 235
Deer Park, IL 60010

Entity Type: 03

Legal Representation

Attorney of Record

Andrew D. Bochner

1,693 trademarks filed View all →

Correspondence Address

Andrew D. Bochner Bochner PLLC

1040 Avenue of the Americas

15th Floor

New York, NY 10018

United States

Trademark Details

Filing Date

September 9, 2024

Registration Date

July 28, 2026

First Use Anywhere

June 3, 2025

First Use in Commerce

June 3, 2025

Published for Opposition

February 10, 2026

Goods & Services

Pharmaceutical preparations and substances for the treatment of endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergic disorders, respiratory diseases, hematologic disorders, neoplastic diseases, edematous disorders, gastrointestinal diseases, tuberculous meningitis infections and trichinosis infections

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 28, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

Jul 28, 2026 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 8, 2026 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 8, 2026 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Jul 7, 2026 SUPC

USE AMENDMENT FILED

Apr 23, 2026 IUAF

TEAS STATEMENT OF USE RECEIVED

Apr 23, 2026 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 7, 2026 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 10, 2026 NPUB

PUBLISHED FOR OPPOSITION

Feb 10, 2026 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 4, 2026 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 15, 2026 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 14, 2026 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 14, 2026 CRFA

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Dec 31, 2025 ERSI

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Oct 28, 2025 GNS3

LETTER OF SUSPENSION E-MAILED

Oct 28, 2025 GNSL

SUSPENSION LETTER WRITTEN

Oct 28, 2025 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 27, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 27, 2025 CRFA

ASSIGNED TO LIE

Oct 27, 2025 ALIE

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Oct 17, 2025 ERSI

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Jun 13, 2025 GNS3

LETTER OF SUSPENSION E-MAILED

Jun 13, 2025 GNSL

SUSPENSION LETTER WRITTEN

Jun 13, 2025 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 12, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 11, 2025 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 11, 2025 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 13, 2025 GNRN

NON-FINAL ACTION E-MAILED

Mar 13, 2025 GNRT

NON-FINAL ACTION WRITTEN

Mar 13, 2025 CNRT

ASSIGNED TO EXAMINER

Mar 11, 2025 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 9, 2024 NWOS

NEW APPLICATION ENTERED

Sep 9, 2024 NWAP

Related Trademarks

More from this Owner

ETON

ETON PHARMACEUTICALS

DESMODA

GALZIN

KHINDIVI

More in Same Class

AKRON FORMULATIONS

WAVY CIRCLE